You are viewing the site in preview mode
Skip to main content
|
Antibody
|
Gerald, Ordonez and Lae (*)
| |
Zhang et al. [22]
| |
|---|
|
Desmin
|
135/149
|
90.6%
|
21/23
|
91%
|
|
Vimentin
|
86/93
|
92.5%
|
NT
| |
|
NSE
|
105/131
|
80.2%
|
NT
| |
|
WT1
|
62/68
|
91.2%
|
16/23
|
70%
|
|
Keratin (not specified)
|
132/149
|
88.6%
|
NT
| |
|
CAM5.2
|
NT
| |
21/23
|
91%
|
|
kerAE1AE3
|
NT
| |
16/23
|
70%
|
|
EMA
|
74/79
|
93.7%
|
NT
| |
|
CD99
|
NT
| |
13/23
|
57%
|
|
Muscle specific actin
|
2/89
|
2.2%
|
NT
| |
|
S-100
|
6/30
|
20%
|
NT
| |
|
Synaptophysin
|
3/19
|
15.8%
|
NT
| |
|
Chromogranin
|
2/68
|
2.9%
|
NT
| |
|
PLAP
|
NT
| |
17/21
|
81%
|
|
Myoglobine
|
NT
| |
5/17
|
29%
|
|
Myogenine
|
0/18
|
0%
|
0/22
|
0%
|
|
Calretinine
|
NT
| |
4/21
|
19%
|
|
HER2
|
NT
| |
7/18
|
39%
|
|
c-kit
|
NT
| |
2/14
|
14%
|
- (*) literature data are retrieved from Gerald et al [36], Ordonez [21] and Lae et al. [25]. Desmin and vimentin show a typical paranuclear dotlike staining. The target genes (PDGF-A, PDGFR beta en TGF-beta3) are almost all positive. NT: Not Tested
